Showing results (551-560 of 607) with videos related to

Sort By:
Pageof 61
BMC Infectious Diseases|April 30, 2014
The prevalence of opportunistic infections and malignancies in autopsied patients with human immunodeficiency virus infection in JapanHarutaka Katano, Tsunekazu Hishima, Makoto Mochizuki, et al.
Plos Pathogens|November 29, 2021
M-Sec induced by HTLV-1 mediates an efficient viral transmissionMasateru Hiyoshi, Naofumi Takahashi, Youssef M Eltalkhawy, et al.
Scientific Reports|January 8, 2022
Factors affecting drug retention of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort studyKosuke Ebina, Toru Hirano, Yuichi Maeda, et al.
Cancer Cell International|November 15, 2022
Potential use of EGFR-targeted molecular therapies for tumor suppressor CYLD-negative and poor prognosis oral squamous cell carcinoma with chemoresistanceAyumi Kanemaru, Satoru Shinriki, Mimi Kai, et al.
Rheumatology (Oxford, England)|March 20, 2025
Sustained efficacy of second-line JAK inhibitors in patients with rheumatoid arthritis: insights from the ANSWER CohortKohei Tsujimoto, Kosuke Ebina, Satomi Okamura, et al.
Nature Microbiology|August 27, 2016
High-affinity monoclonal IgA regulates gut microbiota and prevents colitis in miceShinsaku Okai, Fumihito Usui, Shuhei Yokota, et al.
Hepatology (Baltimore, Md.)|May 12, 2019
Dependency of Cholangiocarcinoma on Cyclin D-Dependent Kinase ActivityGunya Sittithumcharee, Orawan Suppramote, Kulthida Vaeteewoottacharn, et al.
Modern Rheumatology|August 13, 2022
Add-on effectiveness of methotrexate or iguratimod in patients with rheumatoid arthritis exhibiting an inadequate response to Janus kinase inhibitors: The ANSWER cohort studyKosuke Ebina, Toru Hirano, Yuichi Maeda, et al.
Clinical Rheumatology|April 1, 2026
Clinical outcomes of molecular-targeted therapies for rheumatoid arthritis: comparison between orthopaedic surgeons and rheumatologists in the multicenter retrospective ANSWER cohortYuki Etani, Yasutaka Okita, Kohei Tsujimoto, et al.
The FEBS Journal|December 24, 2022
A novel tdTomato transgenic mouse model to visualize FAP-positive cancer-associated fibroblastsFeng Wei, Tomoyuki Uchihara, Atsuko Yonemura, et al.
Pageof 61